DrugPatentWatch Database Preview
Drugs in Development Information for Valerian
Drug Development Status for Valerian: Sponsors, patents, clinical trial progress
Valerian is an investigational drug.
There have been 8 clinical trials for Valerian.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2008.
The most common disease conditions in clinical trials are Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, and Parkinson Disease. The leading clinical trial sponsors are Pascoe Pharmazeutische Praeparate GmbH, Steiner Arzneimittel, Berlin, Germany, and Federal University of the Valleys of Jequitinhonha and Mucuri.
Summary for Valerian
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2008-07-01) |
| Vendors | 0 |
Recent Clinical Trials for Valerian
| Title | Sponsor | Phase |
|---|---|---|
| Therapeutic Effect of an Herbal Medicine on Anxiety | Millet Roux | Phase 3 |
| Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety | Marjan Industria e Comercio ltda | Phase 3 |
| Efficacy and Safety of St. John´s Wort/Valerian Extract Versus Placebo in Children and Adolescents With ADHD | Steiner Arzneimittel, Berlin, Germany | Phase 3 |
Clinical Trial Summary for Valerian
Top disease conditions for Valerian
Top clinical trial sponsors for Valerian
US Patents for Valerian
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
